éŠã®ã·ã¯ã¯æã£ãããæ©ãå§ãŸããŸã
é¡ã®åã§é¡ã®ã±ã¢ã«ã¯ç±å¿ã§ããéŠãèŠèœãšããŠããŸãããšãå€ãã§ãããããéŠã®ç®èã¯é¡ããç®èè ºãå°ãªãèããããèåã®ãµã€ã³ãããæ©ããããã¯ã£ãããšçŸããéšäœã§ããå§¿å¢ã®ç¿æ £ãã¹ããŒããã©ã³ã®äœ¿çšæéãå¢ããã«ã€ããæšªãžã¯ãã§ããææãæ©ãŸã£ãŠããŸãã
ãã®èšäºã§ã¯ãéŠã®ã·ã¯ãã§ããåå ããçæŽ»ç¿æ £ã§ã®äºé²æ³ããããŠCelliniqueïŒã»ãªããã¯å»é¢ïŒã§æ€èšå¯èœãªæœè¡æŠèŠãŸã§ãŸãšããŸãããã³ã©ãŒã²ã³ã±ã¢æœè¡ãæ°ã«ãªãæ¹ã¯ããžã¥ãã«ãã¯ç·åã¬ã€ãããªãžã¥ã©ã³ vs ãžã¥ãã«ãã¯æ¯èŒã¬ã€ãããã²ãåç §ãã ããã
3è¡ãŸãšã
1. éŠã®ç®èã¯é¡ããèãç®èè ºãå°ãªããããèåã»å§¿å¢ã»çŽ«å€ç·ã®3ã€ã®èŠå ãéãªããšã·ã¯ãæ¥éã«æ·±ããªãå¯èœæ§ããããŸãã
2. çæŽ»ç¿æ £ã®æ¹åïŒã¹ããŒããã©ã³ã®å§¿å¢ã»çŽ«å€ç·å¯Ÿçã»ä¿æ¹¿ïŒã¯éŠã®ã·ã¯ã±ã¢ã®åºæ¬ã§ãããã©ã®æœè¡ãšã䞊è¡ã§ããåå°ã§ãã
3. æœè¡ã¯éŠã®éšäœç¹æ§ãšå人ã®ç®èç¶æ ã«ãã£ãŠèšèšãç°ãªããå¹æã»æç¶æéã«ã¯å人差ããããããäºåã«ãŠã³ã»ãªã³ã°ã§é©åæ§ã確èªããããšãå æ±ºã§ãã
1. éŠã®ã·ã¯ã¯ãªãã§ããã®ã§ããïŒ
éŠã®ã·ã¯ã®åå ã¯å€§ãã3ã€ã«åããããŸããç®èå éšã®æ§é çå€åãå€éšåºæ¿ïŒçŽ«å€ç·ã»å§¿å¢ïŒããããŠçèã®åãã§ãã
ç®èå éš â ã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®æžå°
ç®èã®åŒŸåãç¶æããã®ã¯çç®å ã®ã³ã©ãŒã²ã³ãšãšã©ã¹ãã³ã§ãã幎霢ãéãããšã³ã©ãŒã²ã³ã®åæãæžããæ¢åã®ã³ã©ãŒã²ã³ç¹ç¶ã倿§ããŠçç®å±€ãèããªããã·ã¯ãæ·±ããªããŸããç¹ã«éŠã®ç®èã¯é¡ããçç®å±€ãèãç®èè ºãå°ãªããããåãé床ã§èåãé²ãã§ãèŠãç®ã®å€åãããé¡èã«çŸããåŸåããããŸãã
玫å€ç· â çç®ãã¡ãŒãžãšã³ã©ãŒã²ã³åè§£
玫å€ç·AïŒUVAïŒã¯ç®èã®æ·±éšã®çç®ãŸã§å°éããç·ç¶èœçްèïŒfibroblastïŒã®æ©èœãäœäžãããã³ã©ãŒã²ã³åè§£é µçŽ ïŒmatrix metalloproteinaseãMMPïŒã®æŽ»æ§ãé«ããŸãããã®çµæãã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ãæ¥éã«å€±ãããŠåŒŸåãäœäžããã·ã¯ã圢æãããŸããéŠã¯å±å€æŽ»åæã«åžžã«é²åºããŠããéšäœã§ããã«ããããããã玫å€ç·å¯Ÿçãçãã«ãªããããå Žæã§ããããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒPMC12038314 (J Cosmet Dermatol 2025, Choi et al.) · PMC41243364 / PMID 41243364 (Pino et al., J Cosmet Dermatol 2025)
- éŠã®æšªãžã¯ïŒhorizontal neck linesïŒæ²»çã®èšåºç ç©¶ïŒPMC12038314ãn=30åã®å¥³æ§ãå¹³å37æ³ïŒã«ãããŠããã¢ã«ãã³é žåç¬ããã³è€åæœè¡ïŒç®äžå¥é¢ + HAïŒãç®è匟åã»ã³ã©ãŒã²ã³å€ã®æ¹åãå ±åããŸããïŒå°èŠæš¡ç ç©¶ãå人差倧ïŒã
- ãã¢ã«ãã³é žããŒã¹ã¹ãã³ããŒã¹ã¿ãŒã®é¡ã»éŠã»ãã³ã«ããžã®é©çšååãèšåºïŒPMID 41243364ãn=81ïŒã«ãããŠãã·ã¯ã®æ·±ãã»æ°Žåã»åŒŸåçã§çµ±èšçã«ææãªæ¹åãå ±åããŸãããã補åã«ãã£ãŠå¹æãç°ãªãå ŽåããããŸãã
- å¹æã»æç¶æéã¯å人差ããããã¹ãŠã®ç ç©¶çµæãåæ§ã«é©çšãããããã§ã¯ãããŸããã
å§¿å¢ãšã¹ããŒããã©ã³ â éŠã®ç®èã®å埩çãªæãç³ã¿
ã¹ããŒããã©ã³ãèŠããšãã«é ãåã«åŸããå§¿å¢ãç¹°ãè¿ããããšãéŠã®ç®èãåãéšäœã§ç¶ç¶çã«æãç³ãŸããŸããäžæçãªã·ã¯ç·ãé·æéç¹°ãè¿ããããšãåŸã ã«åºå®ããæšªãžã¯ã«ãªããšç¥ãããŠããŸããæè¿ã®ç ç©¶ã§ããã¹ããŒããã©ã³äœ¿çšãé žæ€è§åºŠãå¢å ãããå§¿å¢å€åãåŒãèµ·ããããšãææãããŠããŸãããããã¯ããã¯ïŒtech neckïŒããšããçšèªããã®çŸè±¡ãæã衚çŸãšããŠãã䜿ãããŸãã
åºé žçïŒplatysmaïŒâ éŠã®çèã®èå
éŠã®ç®èã®äžã«ã¯åºé žçïŒplatysmaïŒãšããåºãçèããããŸãã幎霢ãéãããšãã®çèã®åŒŸåãå€åããç®èãšã®ä»çãç·©ãããšã§éŠã®ã·ã¯ãããã¿ãããé¡èã«ãªãå¯èœæ§ããããŸããåºé žçã®å€åã«ãã瞊ãžã¯ïŒéŠã®ãã³ãïŒã¯æšªãžã¯ãšã¯ç°ãªãã¡ã«ããºã ã§çãããããããã«äŒŽãã¢ãããŒããç°ãªããŸãã
| ã·ã¯ã®çš®é¡ | äž»ãªåå | ç¹åŸŽ |
|---|---|---|
| 暪ãžã¯ | å§¿å¢ã»å埩çãªæãç³ã¿ã»ã³ã©ãŒã²ã³æžå° | ã¹ããŒããã©ã³ã®äœ¿çšå§¿å¢ã«ããè¥ã幎霢ã§ãã§ããããšããã |
| 瞊ãžã¯ïŒéŠã®ãã³ãïŒ | åºé žçã®å€åã»ç®äžèèªã®æžå° | äž»ã«äžé«å¹Žå±€ãåºé žçã®æ©èœãšé¢é£ |
| 现ããã·ã¯ã»ä¹Ÿç¥ãžã¯ | 玫å€ç·ãã¡ãŒãžã»æ°Žåæžå°ã»çç®ã®èå | é¡ããå埩ãé ãå Žåããããä¿æ¹¿ã»çŽ«å€ç·å¯ŸçãéèŠ |
2. çæŽ»ç¿æ £ã§ã§ããéŠã®ã·ã¯ã®äºé²ã»ç®¡ç
æœè¡ããå ã«ããããŠæœè¡ãšäžŠè¡ããŠãåºæ¬ãšãªãã®ã¯çæŽ»ç¿æ £ã§ããéŠã®ã·ã¯ã¯åå ãè€åçãªãããæ¥åžžã§æ°ãã€ããããéšåãå ã«ãŸãšããŸãã
玫å€ç·å¯Ÿç â æãéèŠãªäžã€ã®ããš
éŠãŸã§ãã£ãããšæ¥çŒãæ¢ããå¡ãç¿æ £ãæ žå¿ã§ããå±å€ã§é¡ã ã察çããŠéŠãèŠèœãšãã±ãŒã¹ãå€ãã§ãããçç®å ã®ã³ã©ãŒã²ã³åè§£ãé²ãããã§çŽ«å€ç·å¯Ÿçãæãåºæ¬çãªæªçœ®ã§ããSPF30以äžã®è£œåãå€åº30ååã«ååã«å¡ãã2æéããšã«å¡ãçŽãããšãæšå¥šåºæºã§ãã
ã¹ããŒããã©ã³ã»ã¢ãã¿ãŒã®å§¿å¢ç¯æ£
ã¹ããŒããã©ã³ãç®ã®é«ãè¿ãã«æã€ããã¢ãã¿ãŒã®é«ãã調æŽããŠé ãé床ã«äžããªãããã«ããããšãå©ãã«ãªããŸããé·æéåãå§¿å¢ãç¶æããããšèªäœãéŠã®ç®èãžã®å埩çãªåºæ¿ãšãªããããããŸãã«ã¹ãã¬ããããŠå§¿å¢ãå€ããããšãããã§ãããã
éŠã®ä¿æ¹¿
éŠã®ç®èã¯ç®èè ºãå°ãªã也ç¥ããããã§ããæŽé¡åŸã«é¡ãšäžç·ã«éŠãŸã§ä¿æ¹¿å€ãå¡ãç¿æ £ãç®èããªã¢ãç¶æããã®ã«åœ¹ç«ã¡ãŸããã¬ãããŒã«ç³»æåãããããæåã®éŠå°çšè£œåãåèã«ã§ããŸãããé©åæ§ã¯å人ã®ç®èç¶æ ã«ãã£ãŠç°ãªããŸãã
ç¡ç å§¿å¢
暪åãã§å¯ãå§¿å¢ã¯éŠã®ç®èãäžæ¹åã«ç¹°ãè¿ãæãç³ãŸããç°å¢ãäœãåºãå¯èœæ§ããããŸããã§ããã°ä»°åãã§å¯ãå§¿å¢ãéŠã®ã·ã¯äºé²ã«æå©ã ãšããæèŠããããŸããããã¹ãŠã®æ¹ã«åæ§ã«é©çšãããåºæºã§ã¯ãããŸããã
â» çæŽ»ç¿æ £ã®ç®¡çã¯éŠã®ã·ã¯ãå®å šã«ãªããæ¹æ³ã§ã¯ãããŸããã圢æé床ãé ãããç®èã®å¥åº·ãç¶æããåºç€ãšããŠçè§£ããŠããã ããšããã§ãããã
3. æœè¡æŠèŠ â éŠã®éšäœã§æ€èšå¯èœãªãªãã·ã§ã³
çæŽ»ç¿æ £ã®ç®¡çã ãã§æ¢ã«åœ¢æãããéŠã®ã·ã¯ãæ¹åãããã«ã¯éçããããŸãããã®éãç®èç§ã§ã¯ããŸããŸãªæœè¡ãæ€èšããŸãã以äžã¯éŠã®éšäœç®¡çã§äžè¬çã«æ€èšãããæœè¡æŠèŠã§ãã
éèŠãªã®ã¯ã以äžã®ãªãã·ã§ã³ããéŠã®ã·ã¯ã«åžžã«ããããšããæå³ã§ã¯ãªããšããããšã§ããéŠã®ç®èã¯é¡ããèããè¡ç®¡ã»ç¥çµãå¯éããŠãããéšäœã»æ·±åºŠã»å®¹éã®èšèšãçµæã«çŽçµããŸããã©ã®æœè¡ãé©ããŠãããã¯ãå人ã®ç®èç¶æ ãšã·ã¯ã®çš®é¡ãèŠãŠã«ãŠã³ã»ãªã³ã°ã§æ±ºå®ããŸãã
ã¹ãã³ããŒã¹ã¿ãŒç³»ïŒãã¢ã«ãã³é žã»PNç³»ïŒ
ã¹ãã³ããŒã¹ã¿ãŒã¯ããã¢ã«ãã³é žïŒHAïŒãããªãã¯ã¬ãªããïŒPNïŒãªã©ã®çäœé©åæ§æåãçç®å ã«åŸ®çŽ°æ³šå ¥ããŠç®èã®æ°Žåã»åŒŸåã»åçãè£å©ããæœè¡ç³»çµ±ã§ããéŠã®éšäœã®æšªãžã¯ç®¡çã«é©çšããäºäŸãå ±åãããŠããŸãã
ãªãžã¥ã©ã³ïŒRejuranïŒã¯PNïŒããªãã¯ã¬ãªããïŒç³»æåã§ç®èã®åçã»å埩æ¹åãšããŠç¥ãããŠããããžã¥ãã«ãã¯ïŒJuvelookïŒã¯PDLLA + éæ¶æ©ãã¢ã«ãã³é žã§ã³ã©ãŒã²ã³åºæ¿ã®æ¹åã䜵ããŠèæ ®ããã¹ãã³ããŒã¹ã¿ãŒã§ããã©ã¡ãã®è£œåãé¡ã ãã§ãªãéŠã®éšäœã«ãæ€èšå¯èœã§ãããéŠã®ç®èç¹æ§äžãéšäœå¥é©åæ§ãšæ³šå ¥æ·±åºŠã®èšèšãéèŠã§ãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒéåœé£åå»è¬åå®å šåŠïŒMFDSïŒå»çæ©åšåç®æ å ±ïŒnedrug.mfds.go.krïŒÂ· 補é 販売å ãã¡ãŒããªãµãŒããã€ãªå ¬åŒæ å ± · 補é 販売å ãã€ã ã°ããŒãã«ïŒæ ªïŒå ¬åŒæ å ±
- ãªãžã¥ã©ã³ïŒRejuranïŒïŒéåœMFDSå»çæ©åšèš±å¯ èš±å¯çªå·14-825ïŒ2014幎ããã¡ãŒããªãµãŒããã€ãªïŒãæåPN 20mg/mLïŒãµãŒã¢ã³DNAç±æ¥ïŒãéåœåœå èš±å¯åç®ã
- ãžã¥ãã«ãã¯ïŒJuvelookïŒïŒéåœMFDSã®çµç¹ä¿®åŸ©ææïŒåé¡B04230.02(4)ïŒãšããŠèš±å¯ãããPDLLA + éæ¶æ©HA補åã補é 販売å ãã€ã ã°ããŒãã«ïŒæ ªïŒãéåœMFDSèš±å¯ + 欧å·CEåç®ïŒç±³åœèš±å¯å±¥æŽã¯å¥éDBæªç¢ºèªïŒã
- ã¹ãã³ããŒã¹ã¿ãŒæåã®èªåŒµè¡šçŸã¯çŠæ¢ã广ã¯å人差ããã
ãããªãã¹ããã·ã³ïŒBotulinum ToxinïŒ
ãããªãã¹ããã·ã³ã¯çèæŽ»åãäžæçã«èª¿ç¯ããæ¹åŒã§ã·ã¯ç®¡çã«äœ¿çšãããŸããéŠã®éšäœã§ã¯ãåºé žçã®äœçšã§çãã瞊ãžã¯ïŒéŠã®ãã³ãïŒããéŠãšäžé¡ã®å¢çã®ããã¿ã«æ€èšãããå ŽåããããŸãããã ãéŠã¯å€ãã®çèãšæ§é ç©ãå¯éããéšäœã§ãããããæ³šå ¥äœçœ®ã»å®¹éã®èšèšãç¹ã«éèŠã§ããå¹æã®æç¶æéã¯å人差ããããæéãçµã€ãšå ã®ç¶æ ã«æ»ãç¹æ§ããããŸãã
ã³ã©ãŒã²ã³åºæ¿ãã£ã©ãŒ / é«ååçäœææ
ãã¢ã«ãã³é žãã£ã©ãŒä»¥å€ã«ããã³ã©ãŒã²ã³çæãåºæ¿ããé«ååçäœææïŒäŸïŒPDLLAç³»ãã«ã«ã·ãŠã ããããã·ã¢ãã¿ã€ãç³»ïŒç³»çµ±ã®æœè¡ãéŠã®éšäœã®åŒŸå管çã«æ€èšãããå ŽåããããŸãããã®ãããªæœè¡ã¯å¹æãåŸã ã«çŸããæç¶æéã®å人差ã倧ããåŸåã«ãããäºåã«ãŠã³ã»ãªã³ã°ã§é©åæ§ãå¿ ã確èªããå¿ èŠããããŸãã
ãšãã«ã®ãŒããŒã¹æœè¡ïŒHIFUã»é«åšæ³¢ãªã©ïŒ
é«åŒ·åºŠéæè¶ 鳿³¢ïŒHIFUïŒãŸãã¯é«åšæ³¢ïŒRFïŒç³»æœè¡ã¯ç®èã®æ·±ãå±€ãåºæ¿ããŠã³ã©ãŒã²ã³çæãšçµç¹åçž®ãèªå°ããæ¹åŒã§ãéŠã®éšäœã®ããã¿ã»åŒŸåäœäžã®ç®¡çã«æŽ»çšãããŸããæ³šå°æœè¡ãªãã§ç®èãžã®åºæ¿ããªãæ¹åŒãåžæããæ¹ã«æ€èšãããå ŽåããããŸããåæ§ã«çµæã«ã¯å人差ããããã©ã®æœè¡ãåããã¯ã«ãŠã³ã»ãªã³ã°ã§æ±ºå®ããŸãã
| æœè¡ç³»çµ± | äž»ãªã¢ãããŒã | éŠã®éšäœé©çšæã®ç¹èšäºé |
|---|---|---|
| ã¹ãã³ããŒã¹ã¿ãŒïŒHAã»PNç³»ïŒ | æ°Žåã»åçã»ã³ã©ãŒã²ã³è£å©æ¹å | éŠã®ç®èåãã»æ·±åºŠèšèšãéèŠãéšäœå¥é©åæ§ã®ã«ãŠã³ã»ãªã³ã°ãå¿ èŠã |
| ãããªãã¹ããã·ã³ | çèèª¿ç¯ â 瞊ãžã¯ã»å¢çããã¿ | éŠã®çèæ§é ã®æ£ç¢ºãªææ¡ãå¿ é ãæ³šå ¥äœçœ®ã«ãã£ãŠçµæãç°ãªãã |
| ã³ã©ãŒã²ã³åºæ¿ãã£ã©ãŒã»çäœææ | ã³ã©ãŒã²ã³çæåºæ¿ â åŒŸåæ¹å | 广ã®é å»¶ãåäººå·®å€§ãæŒžé²çãªå€åãæåŸ ã |
| ãšãã«ã®ãŒããŒã¹ïŒHIFUã»é«åšæ³¢ïŒ | 深局çµç¹åºæ¿ â 匟åã»ããã¿ | ç®èåãã»éŠã®æ§é ã«ãã£ãŠãã©ã¡ãŒã¿èª¿æŽãå¿ èŠã |
â» äžèšã®å 容ã¯äžè¬çãªæœè¡æŠèŠã§ããã©ã®æœè¡ããèªèº«ã«é©ããŠãããã¯ãéŠã®ç®èç¶æ ã»ã·ã¯ã®çš®é¡ã»å¥åº·æŽãçŽæ¥ç¢ºèªããåŸã«æ±ºå®ãããåäžã®çµæãä¿èšŒã§ããŸãããäžèšã®å å®¹ãæ ¹æ ã«æœè¡ãéžæãããå¿ ãäºåã«ãŠã³ã»ãªã³ã°ãåããŠãã ããã
4. CelliniqueïŒã»ãªããã¯å»é¢ïŒã§ã®éŠã®ã·ã¯ã«ãŠã³ã»ãªã³ã°ã®æ¹æ³
CelliniqueïŒã»ãªããã¯å»é¢ïŒã¯æ±ååºå³¶å±±å€§è·¯ã®ã¢ã³ããšã€ãžã³ã°ç®èç§ã§ãéŠã®éšäœæœè¡ããã ã»ãŽã代衚é¢é·ãçŽæ¥ã«ãŠã³ã»ãªã³ã°ããæœè¡ã»ã¢ãã¿ãŒã±ã¢ãŸã§æ åœããŠããŸãã
éŠã®ã·ã¯ã®ã«ãŠã³ã»ãªã³ã°ã§ã¯ãã©ã®æœè¡ãæåãããããã®æ¹ã®éŠã®ç®èã«ã©ã®ã¢ãããŒããåãããå ã«èŠãŸããã·ã¯ã®çš®é¡ïŒæšªã»çžŠã»çްããã·ã¯ïŒãç®èã®åããæ¢åŸæœè¡æŽãæçšè¬ãçæŽ»ç¿æ £ãªã©ãåãããŠæ€èšããæ®µéçãªç®¡çæ¹éããæ¡å ããŸãã
éŠã¯é¡ãšç°ãªãèãããªã±ãŒããªç®èãå¯éããçèã»è¡ç®¡æ§é ããããããèšè𿮵éã§ååãªæéããããããšãéèŠã§ããCelliniqueïŒã»ãªããã¯å»é¢ïŒã§ã¯æœè¡ã®å®æœæç¡ã«ããããããã«ãŠã³ã»ãªã³ã°ã®ã¿ãåžæãããæ¹ããæ°è»œã«ãé£çµ¡ãã ããã
5. éŠã®ã·ã¯æœè¡ã®æ³šæäºé ãšå¯äœçšã®å¯èœæ§
éŠã®éšäœæœè¡ã¯ãã¹ãŠã®æ¹ã«é©ããŠãããšã¯éããŸããã以äžã«è©²åœããå Žåã¯äºåã«ãŠã³ã»ãªã³ã°ã§å¿ ããäŒããã ããã
æœè¡åã«ãäŒãããã ãäºé
- åŠåš äžã»æä¹³äžããŸãã¯äºå®ãããŠããå Žå
- éŠã»é žæ€éšäœã®æè¡æŽãŸãã¯çã¿ãããå Žå
- æååºå€ã»æè¡å°æ¿å€ã»å ç«æå¶å€ãæçšäžã®å Žå
- èªå·±å ç«çŸæ£ãŸãã¯ã±ãã€ãã®æ¢åŸæŽãããå Žå
- æœè¡éšäœã«æŽ»åæ§ã®ææã»ççãããå Žå
- 麻é å€ïŒãªãã«ã€ã³ãªã©ïŒãŸãã¯æœè¡æåã«ã¢ã¬ã«ã®ãŒã®æ¢åŸæŽãããå Žå
äžè¬çã«ãæ¡å ããå¯äœçšã®å¯èœæ§
- æœè¡éšäœã®äžæçãªè «ãã»èµ€ã¿ã»ããïŒã»ãšãã©ã¯æ°æ¥ä»¥å ã«å埩ïŒ
- 泚å°è·¡ã»äžæçãªå§çã»åŒã£åŒµãæ
- ãŸãã«çµç¯æã»ç¡¬çµïŒæéã®çµéãšãšãã«å®å®åããããšãå€ãïŒ
- éåžžã«ãŸãã«ææã»ã¢ã¬ã«ã®ãŒåå¿ãæç¶ããç°åžžåå¿
å¯äœçšã®çºçæç¡ã»çšåºŠã¯å人差ããããŸããæœè¡åŸã«ç°åžžåå¿ãããã°CelliniqueïŒã»ãªããã¯å»é¢ïŒã«ãããé£çµ¡ãã ããã
çµæã»æç¶ã»é©åæ§ã¯å人ã®ç®èç¶æ ã»å¹Žéœ¢ã»ç掻ãã¿ãŒã³ã«ãã£ãŠå·®ããããåäžã®çµæãä¿èšŒã§ããŸããã
æœè¡ã«ã¯äžæçãªçŽ æã»æµ®è «ãªã©ã®å¯äœçšã®å¯èœæ§ããããçŠå¿äºé ãããå Žåããããããäºåã«ãŠã³ã»ãªã³ã°ã§ç¢ºèªããŸãã
ããããã質åïŒFAQïŒ
Q1. éŠã®ã·ã¯ã¯é¡ã®ã·ã¯ãã管çãé£ããã§ããïŒ
éŠã®ç®èã¯é¡ããèãç®èè ºãå°ãªããåºé žçãšããçèã«é£æ¥ããŠããæ§é ãè€éã§ããåãåå ãäœçšããŠãå€åãæ©ãçŸããããšããããå埩ãéšäœã«ãã£ãŠç°ãªãå ŽåããããŸããããã管çãäžå¯èœãšããããã§ã¯ãããŸãããçæŽ»ç¿æ £ã®æ¹åãšé©åãªæœè¡ãçµã¿åãããããšã§ãç¶æ ã®æ¹åãé²è¡é床ãé ãããã®ã«åœ¹ç«ã¡ãŸããã©ã®ã¢ãããŒããåããã¯ç®èç¶æ ãçŽæ¥ç¢ºèªããåŸã«æ±ºå®ããŸãã
Q2. ã¹ããŒããã©ã³ããã䜿ããšæ¬åœã«éŠã®ã·ã¯ãã§ããŸããïŒ
é ãåã«åŸããå§¿å¢ãç¹°ãè¿ããããšéŠã®ç®èãåãäœçœ®ã§ç¹°ãè¿ãæãç³ãŸããé·æéç¶ããšãã®éšäœã暪ãžã¯ãšããŠåºå®ãããå¯èœæ§ããããŸããã¹ããŒããã©ã³ã®ç»é¢ãç®ã®é«ãè¿ãã«æã€ãããŸãã«ã¹ãã¬ããããããšãæšå¥šãããçç±ã§ãããã ãæ¢ã«åœ¢æãããã·ã¯ãå§¿å¢ç¯æ£ã ãã§å®å šã«æ»ãããšã¯é£ããããããªãé²è¡ãé ããã圹å²ãšããŠçè§£ããã®ãçŸå®çã§ãã
Q3. éŠã®ã·ã¯ã«ã¹ãã³ããŒã¹ã¿ãŒæœè¡ãåããããŸããïŒ
HAã»PNç³»ã¹ãã³ããŒã¹ã¿ãŒãéŠã®éšäœã®æšªãžã¯ç®¡çã«æ€èšãããå ŽåããããŸãããã ãéŠã®ç®èã¯é¡ããèãæ§é ãç°ãªããããã©ã®è£œåãã©ã®ãããªæ¹åŒã§é©çšãããæ éã«èšèšããå¿ èŠããããŸããã«ãŠã³ã»ãªã³ã°ã§éŠã®ç®èç¶æ ãšã·ã¯ã®çš®é¡ãå ã«ææ¡ããåŸã«ãªãã·ã§ã³ããæ¡å ããŸããçµæã«ã¯å人差ããããŸãã
Q4. éŠã®ã·ã¯ã«ãããã¯ã¹ã¯å¹æçã§ããïŒ
ãããªãã¹ããã·ã³ã¯çžŠæ¹åã®éŠã®ãã³ãïŒåºé žçã®æŽ»æ§ã§çããã·ã¯ïŒã«æ€èšãããå ŽåããããŸããæšªãžã¯ã«ã¯ãããªãã¹ããã·ã³ããã¹ãã³ããŒã¹ã¿ãŒã»ãã£ã©ãŒç³»ãåªå æ€èšãããããšãå€ãã§ããã©ã®ã·ã¯ãã«ãã£ãŠã¢ãããŒããç°ãªããããã©ã®æœè¡ãå ã«æ€èšãããã¯ã«ãŠã³ã»ãªã³ã°ã§ã·ã¯ã®çš®é¡ãçŽæ¥ç¢ºèªããåŸã«æ±ºå®ããŸãã
Q5. éŠã®ã·ã¯æœè¡ã¯ã©ããããæç¶ããŸããïŒ
æç¶æéã¯æœè¡ã®çš®é¡ã»å人ã®ç®èç¶æ ã»çæŽ»ç¿æ £ã«ãã£ãŠå·®ã倧ããåŸåã«ãããŸããã¹ãã³ããŒã¹ã¿ãŒç³»ã¯äžè¬çã«æ°ã¶æããããªãã¹ããã·ã³ã¯æ°ã¶æãåºæºãšããŠèšåãããŸããå人差ããããåã广ãä¿èšŒã§ããŸãããæç¶æéãè¿ã¥ããŠãããå¿ èŠã«å¿ããŠåæœè¡ãæ€èšããŸãã
Q6. çæŽ»ç¿æ £ã®ç®¡çã ãã§ãéŠã®ã·ã¯ã¯æ¹åã§ããŸããïŒ
æ¢ã«åœ¢æãããæšªãžã¯ãæ·±ãã·ã¯ãçæŽ»ç¿æ £ã®æ¹åã ãã§å®å šã«æ»ãããšã¯é£ããã§ãã玫å€ç·å¯Ÿçã»ä¿æ¹¿ã»å§¿å¢ç¯æ£ã¯ãããªãé²è¡ãé ãããæœè¡å¹æãé·ãç¶æããããã®åºç€ãšããŠæŽ»çšããã®ãçŸå®çãªæåŸ ã§ãã现ããã·ã¯ã»è質ã¬ãã«ã®åæç®¡çã«ã¯çæŽ»ç¿æ £ã ãã§ãæå³ã®ããå€åãããå ŽåããããŸãã
Q7. ã«ãŠã³ã»ãªã³ã°ã ãåããããŸããïŒ
ãã¡ããã§ããæœè¡ã®å®æœæç¡ã«ããããããã«ãŠã³ã»ãªã³ã°ã®ã¿ãåžæãããæ¹ããã€ã§ããé£çµ¡ãã ãããéŠã®ã·ã¯ã®çš®é¡ãšãèªèº«ã®ç®èç¶æ ã«åã£ãç®¡çæ¹éãå ã«ææ¡ããããšãè¯ãåºçºç¹ã§ãã02-6203-3434ãŸãã¯ã«ã«ãªããŒã¯ã§ãæ°è»œã«ãåãåãããã ããã
Q8. é¡ãšéŠã®ã·ã¯ãäžç·ã«ç®¡çã§ããŸããïŒ
å¯èœãªå Žåãå€ãã§ãããã ãé¡ãšéŠã¯ç®èã®åãã»æ§é ã»é©ããæœè¡èšèšãç°ãªãå ŽåããããããäžåºŠã«ãŸãšããŠé²ããã«é åºãšééãåãããŠèšèšããããšãå®å šã§ããçŸåšé²è¡äžã®é¡ã®æœè¡ãããå Žåã¯ãã«ãŠã³ã»ãªã³ã°ã§äžç·ã«èª¿æŽããŸãã
ãŸãšã
éŠã®ã·ã¯ã¯é¡ããæ©ã幎霢ã§ãå§¿å¢ã»çŽ«å€ç·ã»èåãéãªã£ãŠçããããšãå€ãã§ããããã ãæ¥åžžã§æ°ãã€ããéšåããããæ¢ã«åœ¢æãããã·ã¯ã«ã¯å人ã®ç¶æ ã«åã£ãæœè¡ã®æ€èšã圹ç«ã€å¯èœæ§ããããŸãã
CelliniqueïŒã»ãªããã¯å»é¢ïŒïŒæ±å島山倧路ïŒã§ã¯ããã ã»ãŽã代衚é¢é·ãæåã®ã«ãŠã³ã»ãªã³ã°ããæœè¡ã»ã¢ãã¿ãŒã±ã¢ãŸã§çŽæ¥æ åœããŠããŸããéŠã®ã·ã¯ç®¡çã«ãèå³ãããæ¹ã¯ãã©ã®ãããªçš®é¡ã®ã·ã¯ãããŸãææ¡ããã«ãŠã³ã»ãªã³ã°ããå§ããããšããå§ãããŸããã³ã©ãŒã²ã³ã±ã¢ãæ°ã«ãªãæ¹ã¯ãžã¥ãã«ãã¯ç·åã¬ã€ããšãªãžã¥ã©ã³ vs ãžã¥ãã«ãã¯æ¯èŒã¬ã€ãããã²ãåç §ãã ããã
â ãã¡ã¯ããã§ãã¯å®äºã¬ããŒã
ãã®èšäºã®äž»èŠãªå»çæ å ±ã¯ä»¥äžã®åºå žãã確èªããŸããã
- PMC12038314 (PMID 40296541ãChoi et al.ãJ Cosmet Dermatol 2025) â "Evaluating the Efficacy of Acupotomy Subcision and Hyaluronic Acid Injections for Neck Wrinkles: A Randomized Trial"ïŒn=30åã®å¥³æ§ïŒããã¢ã«ãã³é žåç¬ããã³è€åæœè¡ vs ç®è匟åã»ã³ã©ãŒã²ã³å€æ¹åãå°èŠæš¡äºåç ç©¶ãå人差倧ã
- PMID 41243364 / PMC12620603 (Pino et al.ãJ Cosmet Dermatol 2025) â "Clinical and Biometric Assessment of a Hyaluronic Acid-Based Skin Booster for Face, Neck and Décolleté Rejuvenation"ïŒn=81ïŒãéŠãå«ã3éšäœã¹ãã³ããŒã¹ã¿ãŒãã·ã¯ã®æ·±ãã»æ°Žåã»åŒŸåã®çµ±èšçæææ¹åãå ±åã補åã«ãã£ãŠçµæãç°ãªãå Žåããã
- éåœé£åå»è¬åå®å šåŠïŒMFDSïŒå»çæ©åšåç®æ å ±ïŒnedrug.mfds.go.krïŒ â ãªãžã¥ã©ã³ èš±å¯çªå·14-825ïŒ2014幎ããã¡ãŒããªãµãŒããã€ãªãPN 20mg/mL ãµãŒã¢ã³DNAç±æ¥ïŒïŒãžã¥ãã«ãã¯åé¡B04230.02(4) PDLLA + éæ¶æ©HAãé©å¿çãæäººã®é¡é¢éšã·ã¯ãäžæçã«æ¹åãã
- UVããã³MMPã¡ã«ããºã â UVAãçç®å ã®MMP掻æ§âã»ã³ã©ãŒã²ã³åè§£ã¡ã«ããºã ã¯æ¢åã®ç®èç§åŠæç®ïŒSkin Aging Systematic ReviewãCosmetics 2025ïŒã«åºã¥ãäžè¬æ å ±ãšããŠèšè¿°ã
- ããã¯ããã¯ïŒtech neckïŒå§¿å¢ç ç©¶ â ã¹ããŒããã©ã³äœ¿çšãšé žæ€å±æ²è§åºŠå¢å ã®é¢é£æ§ç ç©¶ïŒBarczyk-Pawelec et al.ïŒã¯å»åŠæç®å ã§ã®èšåã¬ãã«ã§ãããéŠã®ã·ã¯ãšã®çŽæ¥çãªå æé¢ä¿ã¯ç¢ºå®çãªããŒã¿ãªã â ç·©å衚çŸã§èšè¿°ã
- åºé žçïŒplatysmaïŒé¢é£æ å ± â StatPearlsã»PubMedããŒã¹ã®äžè¬è§£ååŠæ¡å ã¬ãã«ã
- ãžã¥ãã«ãã¯ã®ç±³åœèš±å¯æç¡ â FDA accessdata DBæªç¢ºèªãéåœMFDSèš±å¯ + 欧å·CEç¯å²ã®ã¿ã§èšè¿°ããç±³åœFDAèš±å¯ãã®æå®ãªãã
- ã¹ãã³ããŒã¹ã¿ãŒå¹æã®è¡šçŸ â ä¿èšŒã»æå®è¡šçŸãªããå人差ã»å¯äœçšã®å¯èœæ§æç€ºã广æ°å€ã®æå®ãªãã
å»åŠçå
責äºé
æ¬ã³ã³ãã³ãã¯äžè¬çãªå¥åº·æ
å ±ã®æäŸãç®çãšããŠãããå人å¥ã®èšºæã»æ²»çã¯å¿
ãå°éå»ã«ãçžè«ãã ããã
CelliniqueïŒã»ãªããã¯å»é¢ïŒã«ãŠã³ã»ãªã³ã°ã»äºçŽ
ãœãŠã«ç¹å¥åžæ±ååºå³¶å±±å€§è·¯228 å»¶ä¹ãã«2éãB1
é»è©± 02-6203-3434
蚺çæé æãé 10:00-19:00 / æ¯ææçµåææ¥ 10:00-16:30



